Help Your At-Risk Patients

While it is ideal to remotely and continuously monitor all medical-surgical floor patients, we know that limited resources and time make it unfeasible for many institutions. The three targeted patient populations where our remote continuous monitoring solutions best align to provide the greatest impact are:

Opioids

Patients on opioids are at risk for opioid-induced respiratory depression (OIRD).

Opioid-induced respiratory depression (OIRD) is a risk on the medical-surgical floor: Approximately 11 million patients receive opioids on the medical-surgical floor each year.([FOOTNOTE=Economic Model from Premier Database for # of Patients on Opioids: 5.2M in Surgical Ward + 5.8M in Medical Ward. Data extracted and analyzed 2019.],[ANCHOR=Economic Model from Premier Database for # of Patients on Opioids: 5.2M in Surgical Ward + 5.8M in Medical Ward. Data extracted and analyzed 2019.],[LINK=]) While medical-surgical patients are low acuity, 46 percent of patients receiving opioids on the general care floor experience respiratory depression.([FOOTNOTE=Khanna A, Bergese S, Jungquist CR, Morimatsu H, Uezono S, Lee S. Prediction of opioid-induced respiratory depression on inpatient wards using continuous capnography and oximetry: an international prospective, observational trial. Anesth Analg. 131(4):1012–1024, October 2020.],[ANCHOR=],[LINK=])

Sleep disordered breathing

Patients with diagnosed or undiagnosed SDB are at heightened risk for complications while in the hospital (including OIRD).

Undiagnosed obstructive sleep apnea is prevalent in the acute-care hospital and is a known clinical problem on the medical-surgical floor. Our remote continuous monitoring solution may help you identify patients who may have undiagnosed sleep apnea or sleep disordered breathing.

Tracheostomy Patients

Patients with artificial airways (e.g. tracheostomy patients) are at risk.

These patients are at risk for respiratory compromise if their tracheostomy tube either becomes occluded or displaced or there is an air leak in cuffed tube patients. Continuous monitoring of pulse oximetry (oxygenation) and capnography (ventilation) may help you manage patients with a tracheostomy.

PRODIGY Risk Prediction Tool

The PRODIGY patient risk stratification tool can help you better determine and stratify which patients should be prioritized for remote continuous monitoring.

PRODIGY is a prospective, international multicenter study to identify individuals at high risk for OIRD, a form of respiratory compromise. The PRODIGY study found that 46 percent of hospitalized patients receiving parenteral opioids experienced significant respiratory depression episodes. Undetected, these may lead to more serious events - including respiratory failure. With the publication of the PRODIGY study, the PRODIGY Risk Prediction Tool is now available. It provides an easy to use, internally-validated means of scoring risk of OIRD based on 5 easy to obtain variables.

Download the PRODIGY Risk Prediction Tool, view an infographic of key study findings, download a Frequently Asked Questions document, or view the PRODIGY study at a glance to learn more.

  • The Microstream™ capnography, Nellcor™ pulse oximetry, and Vital Sync™ remote patient monitoring systems should not be used as the sole basis for diagnosis or therapy and are intended only as an adjunct in patient assessment.